Subscribe to RSS
DOI: 10.1055/s-0029-1217713
Concise Asymmetric Synthesis of Antimalarial Alkaloid (+)-Febrifugine
Publication History
Publication Date:
29 July 2009 (online)

Abstract
An asymmetric total synthesis of antimalarial alkaloid (+)-febrifugine is accomplished in 23% overall yield over 14 steps from readily available starting materials. The synthesis features a SmI2-mediated reductive cross-coupling of chiral N-tert-butanesulfinyl imine with aldehyde.
Key words
antimalarial - asymmetric synthesis - febrifugine - cross-coupling
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Koepfli JB.Mead JF.Brockman JA. J. Am. Chem. Soc. 1947, 69: 1837 -
1b
Koepeli JB.Mead JF.Brockman JA. J. Am. Chem. Soc. 1949, 71: 1048 -
1c
Ablondi F.Gordon S.Morton J.Williams JH.
J. Org. Chem. 1952, 17: 14 -
1d
Barringer DF.Beakelhammer GB.Carter SD.Goldman L.Lanzilotti AE. J. Org. Chem. 1973, 38: 1933 -
1e
Barringer DF.Beakelhammer GB.Wayne RS. J. Org. Chem. 1973, 38: 1937 -
1f
Kato M.Inaba M.Itahana H.Ohara E.Nakamura K.Uesato S.Inouye H.Fujita T. Shoyakugaku Zasshi 1990, 44: 288 -
2a
Kobayashi S.Ueno M.Suzuki R.Ishitani H. Tetrahedron Lett. 1999, 40: 2175 -
2b
Kobayashi S.Ueno M.Suzuki R.Ishitani H.Kim HS.Wataya Y. J. Org. Chem. 1999, 64: 6833 -
3a
Fishman M.Cruickshank PA. J. Med. Chem. 1970, 13: 155 -
3b
Chien P.-L.Cheng CC. J. Med. Chem. 1970, 13: 867 -
3c
De Smet PAGM. Drugs 1997, 54: 801 -
4a
Takeuchi Y.Abe H.Harayama T. Chem. Pharm. Bull. 1999, 47: 905 -
4b
Takeuchi Y.Hattori M.Abe H.Harayama T. Synthesis 1999, 1814 -
4c
Takeuchi Y.Azuma K.Takakura K.Abe H.Harayama T. Chem. Commun. 2000, 1643 -
4d
Okitsu O.Suzuki R.Kobayashi S. Synlett 2000, 989 -
4e
Taniguchi T.Ogasawara K. Org. Lett. 2000, 2: 3193 -
4f
Takeuchi Y.Azuma K.Takakura K.Abe H.Kim HS.Wataya Y.Harayama T. Tetrahedron 2001, 57: 1213 -
4g
Ooi H.Urushibara A.Esumi T.Iwabuchi Y.Hatakeyama S. Org. Lett. 2001, 3: 953 -
4h
Sugiura M.Kobayashi S. Org. Lett. 2001, 3: 477 -
4i
Sugiura M.Hagio H.Hirabayashi R.Kobayashi S. J. Org. Chem. 2001, 66: 809 -
4j
Sugiura M.Hagio H.Hirabayashi R.Kobayashi S. J. Am. Chem. Soc. 2001, 123: 12510 -
4k
Huang P.-Q.Wei BG.Ruan Y.-P. Synlett 2003, 1663 -
4l
Katoh M.Matsune R.Nagase H.Honda T. Tetrahedron Lett. 2004, 45: 6221 -
4m
Zhu S.-R.Meng L.Zhang Q.Wei L. Bioorg. Med. Chem. Lett. 2006, 16: 1854 -
4n
Ashoordazeh A.Caprio V. Synlett 2005, 346 -
4o
Katoh M.Matsune R.Honda T. Heterocycles 2006, 67: 189 -
4p
Kikuchi H.Yamamoto K.Horoiwa S.Hirai S.Kasahara R.Hariguchi N.Matsumoto M.Oshima Y. J. Med. Chem. 2006, 49: 4698 -
4q
Sieng B.Ventura OL.Bellosta V.Cossy J. Synlett 2008, 1216 -
4r
Wee AGH.Fan G.-J. Org. Lett. 2008, 10: 3869 -
5a
Zhong Y.-W.Dong Y.-Z.Fang K.Isumi K.Xu M.-H.Lin G.-Q. J. Am. Chem. Soc. 2005, 127: 11956 -
5b
Zhong Y.-W.Xu M.-H.Lin G.-Q. Org. Lett. 2004, 6: 3953 -
5c
Zhong Y.-W.Isumi K.Xu M.-H.Lin G.-Q. Org. Lett. 2004, 6: 4747 - 7
Mosset P.Pointeau P.Aubert F.Lellouche JP.Beaucourt JP.Gree R. Bull. Soc. Chem. Fr. 1990, 298 -
8a
Huang SL.Omura K.Swern D. J. Org. Chem. 1976, 41: 3329 -
8b
Huang SL.Omura K.Swern D. Synthesis 1978, 297 -
9a
Liu GC.Cogan DA.Owens TD.Tang TP.Ellman JA. J. Org. Chem. 1999, 64: 1278 -
9b
Ellman JA.Owens TD.Tang TP. Acc. Chem. Res. 2002, 35: 984 -
9c
Huang ZY.Zhang M.Wang Y.Qin Y. Synlett 2005, 1334 - 10
Crich D.Smith M. J. Am. Chem. Soc. 2001, 123: 9015 - 11
Martinelli MJ.Nayyar NK.Moher ED.Dhokte UP.Pawlak JM.Vaidyanathan R. Org. Lett. 1999, 1: 447 - 12
Clink RD.Forsyth C. J. Org. Chem. 1995, 60: 8122 - 13
Cruickshank PA.Fishman M. J. Org. Chem. 1969, 34: 3060 - 14
Dess DB.Martin JC. J. Org. Chem. 1983, 48: 4155
References and Notes
Indeed, a preliminary study, which
utilized aldehyde A and imine B (Scheme
[6]
)
as the substrates to investigate the impact of a stereocenter adjacent
to the reaction site, has established that the N-sulfinyl
group determines the stereochemistry of the product C,
whose structure was confirmed by X-ray crystallography (CCDC deposit
no. 724597). These data can be obtained
free of charge from
The Cambridge Crystallographic Data
Centre via www.ccdc.cam.ac.uk/data_request/cif.

Scheme 6
Selected Experiment
and Spectroscopic DataPreparation of Compound 4
To
the solution of SmI2 (4.0 mmol in 20 mL of THF) the solution
of imine 5 (480 mg, 1.90 mmol), aldehyde 6 (1.14 g, 3.80 mmol) and t-BuOH
(380 µL, 4.0 mmol) in 20 mL of THF was dropped in slowly
under argon at -78 ˚C.
The mixture was
stirred vigorously for 7 h at the same temperature and then quenched
by 10 mL sat. Na2S2O3 aq solution.
The organic layer was separated, and the aqueous layer was extracted
with EtOAc. The combined organic extracts were washed by sat. brine
and then dried over anhyd MgSO4, filtered, and concentrated
under vacuum. After flash silica gel chromatography, 952 mg (85%)
of the pure product 4 was obtained as yellow
oil.
Compound 4: [α]D
²8 +33.0
(c 2.70, CHCl3). ¹H
NMR (300 MHz, CDCl3): δ = 7.65 (d, J = 6.9 Hz,
4 H), 7.45-7.26 (m, 6 H), 4.46 (d, J = 4.8
Hz, 1 H), 4.29 (m, 1 H), 4.12 (dd, J = 8.1, 5.7
Hz, 1 H), 3.74-3.67 (m, 3 H), 3.52 (t, J = 7.8
Hz, 1 H), 3.42 (m, 1 H), 3.05 (d, J = 4.8
Hz, 1 H), 1.89-1.52 (m, 6 H), 1.40 (s, 3 H), 1.36 (s, 3
H), 1.24 (s, 9 H), 1.05 (s, 9 H). ¹³C NMR
(75 MHz, CDCl3): δ = 135.48, 133.67,
129.55, 127.57, 109.57, 73.65, 72.59, 69.65, 63.79, 57.96, 55.57,
32.16, 29.77, 29.14, 26.83, 26.79, 25.73, 22.62, 19.11. FT-IR (thin film):
3414, 3283, 2983, 2959, 2933, 2860, 1112, 1052 cm-¹. ESI-MS: m/z = 576.3 [M + H]+,
598.3 [M + Na]+.
MALDI-HRMS: m/z calcd for C31H49NO5SSiNa [M + Na]+: 598.2993;
found: 598.3011.
Compound 14: [α]D
²5 +64.6
(c 0.60, CHCl3). ¹H
NMR (400 MHz, CDCl3): δ = 8.26 (m,
1 H), 7.98 (s, 1 H), 7.81-7.73 (m, 2 H), 7.51 (m, 1 H),
7.32-7.24 (m, 5 H), 4.96 (d, J = 17.6
Hz, 1 H), 4.75 (d, J = 17.6
Hz, 1 H), 4.63-4.52 (m, 2 H), 4.42 (s, 1 H), 3.62-3.59
(m, 2 H), 3.11-3.03 (m, 2 H), 2.75 (m, 1 H), 2.05-1.92
(m, 2 H), 1.62-1.47 (m, 2 H), 1.38-1.33 (m, 9
H). ¹³C NMR (100 MHz, CDCl3): δ = 200.67,
160.95, 148.33, 146.60, 138.18, 134.44, 128.26, 127.70, 127.61,
127.54, 127.29, 126.67, 121.86, 74.29, 70.81, 61.98, 54.80, 54.70, 43.16,
42.05, 24.10, 23.24, 19.62. FT-IR (thin film): 2928, 2870, 1308,
936 cm-¹. ESI-MS: m/z = 512.4 [M + H]+,
534.4 [M + Na]+.
ESI-HRMS: m/z calcd for C27H34N3O5S [M + H]+:
512.2214; found: 512.2232.
Compound 1:
mp 137-139 ˚C; [α]D
²6 +27.3
(c 0.45, EtOH) [lit.¹b mp
139-140 ˚C; [α]D
²5 +28.0
(c 0.5, EtOH)]. ¹H
NMR (500 MHz, CDCl3): δ = 8.28 (m,
1 H), 7.89 (s, 1 H), 7.77-7.72 (m, 2 H), 7.52 (t, J = 6.7 Hz,
1 H), 4.90 (d, J = 17.7
Hz, 1 H), 4.81 (d, J = 17.7
Hz, 1 H), 3.28 (br s, 1 H), 3.11 (dd, J = 15.9,
3.9 Hz, 1 H), 2.96 (d, J = 11.0
Hz, 1 H), 2.87 (br d, J = 3.9
Hz, 1 H), 2.65 (dd, J = 15.9,
6.7 Hz, 1 H), 2.58 (m, 1 H), 2.08 (br d, J = 10.7
Hz, 1 H), 1.84 (br, 2 H), 1.70 (br d, J = 12.4
Hz, 1 H), 1.52 (br d, J = 12.8
Hz, 1 H), 1.34 (br d, J = 10.1
Hz, 1 H). ¹³C NMR (125 MHz, CDCl3): δ = 202.64, 161.01,
148.23, 146.39, 134.54, 127.64, 127.44, 126.80, 121.88, 72.26, 60.18,
54.85, 45.97, 44.04, 34.48, 25.65. FT-IR (thin film): 3304, 3287,
2941, 2931, 2858, 2814, 1722, 1674, 1614, 1475, 1363, 1084, 773,
698 cm-¹. ESI-MS:
m/z = 302.2 [M + H]+,
324.2 [M + Na]+.
ESI-HRMS: m/z calcd for C16H20N3O3 [M + H]+:
302.1500; found: 302.1499.